Actually, a series of extracts from natural products such as Luteolin, quercetin, apigenin, fisetin, and myricitrin are potential AR inhibitors, and found to be beneficial for NAFLD/NASH (Grewal et al., 2016). The gene discussed is AR; the disease is metabolic dysfunction-associated steatotic liver disease.